Press "Enter" to skip to content

Orion Biotechnology Reports Additional Positive Preclinical Data for OB-002 in the Treatment of Colorectal Cancer – PRNewswire

admin 0

Orion Biotechnology Reports Additional Positive Preclinical Data for OB-002 in the Treatment of Colorectal Cancer  PRNewswire

OTTAWA, Ontario, June 20, 2019 /PRNewswire/ — Orion Biotechnology Canada Ltd., today announced new preclinical data evaluating the efficacy of OB-002 …

“colorectal cancer” – Google News

(Visited 3 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *